Drugmaker Orchid Chemicals, party to hectic share purchase activities by a Ranbaxy group entity recently, is attracting a new investor -- P...

Ranbaxy said the pact with Orchid involved multiple geographies and therapies for both finished dosage forms and active pharmaceutical ingr...

Orchid Chemicals’ shares plunged 12.5% or Rs 40 to Rs 279 on Thursday from Wednesday’s close of Rs 319 at BSE.

The promoters of mid-sized pharma company Strides Arcolab have increased their holding in the company by a little over 4% in recent weeks.

The Ranbaxy Group has come within striking distance of an open offer for Chennai-based drug maker Orchid Chemicals & Pharmaceuticals.

Solrex Pharmaceuticals, the surprise raider which mopped up 11.4% stake in the Chennai-based drug maker, has returned to the market after a...

Ranbaxy, which has been linked to a hostile takeover bid of Orchid Chemicals, has said it does not believe in such practices.

Solrex will have to fork out an extra Rs 400-500 crore to buy a further 20% stake in case it comes with an open offer.

As a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...

A creeping acquisition has begun in the shares of Chennai-based Orchid Chemicals & Pharmaceuticals which has become vulnerable to acquisiti...